Literature DB >> 15042332

MR imaging and spectroscopy in juvenile Huntington disease.

Mark Schapiro1, Kim M Cecil, Jason Doescher, Alaina M Kiefer, Blaise V Jones.   

Abstract

Juvenile Huntington disease manifests differently from adult Huntington disease and has more variability in presentation. We describe a child with cognitive decline and adventitial movements in whom Huntington disease was confirmed with genetic testing. MR imaging showed abnormal T2 prolongation in the putamina and progressive caudate atrophy, and MR spectroscopy revealed elevated myoinositol and diminished N-acetyl aspartate, creatine, and phosphocreatine. Imaging findings of caudate atrophy and abnormal T2 prolongation in the putamina with MR spectroscopy findings consistent with dense gliosis can be helpful indicators of juvenile Huntington disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042332     DOI: 10.1007/s00247-004-1159-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  12 in total

1.  Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study.

Authors:  L Harms; H Meierkord; G Timm; L Pfeiffer; A C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

2.  1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers.

Authors:  B G Jenkins; H D Rosas; Y C Chen; T Makabe; R Myers; M MacDonald; B R Rosen; M F Beal; W J Koroshetz
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Confidence intervals for predicted age of onset, given the size of (CAG)n repeat, in Huntington's disease.

Authors:  G Lucotte; J C Turpin; O Riess; J T Epplen; I Siedlaczk; F Loirat; S Hazout
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

4.  Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.

Authors:  H D Rosas; J Goodman; Y I Chen; B G Jenkins; D N Kennedy; N Makris; M Patti; L J Seidman; M F Beal; W J Koroshetz
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

5.  Neurodegenerative diseases of childhood: MR and CT evaluation.

Authors:  S A Mirowitz; K Sartor; A J Prensky; M Gado; F J Hodges
Journal:  J Comput Assist Tomogr       Date:  1991 Mar-Apr       Impact factor: 1.826

6.  Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

Authors:  W J Koroshetz; B G Jenkins; B R Rosen; M F Beal
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

7.  Clinical correlation of striatal 1H MRS changes in Huntington's disease.

Authors:  R Sánchez-Pernaute; J M García-Segura; A del Barrio Alba; J Viaño; J G de Yébenes
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

8.  Genetic testing of children at risk for Huntington's disease. US Huntington Disease Genetic Testing Group.

Authors:  M A Nance
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

9.  Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.

Authors:  H D Rosas; W J Koroshetz; Y I Chen; C Skeuse; M Vangel; M E Cudkowicz; K Caplan; K Marek; L J Seidman; N Makris; B G Jenkins; J M Goldstein
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

10.  Juvenile Huntington disease: CT and MR features.

Authors:  V B Ho; H S Chuang; M J Rovira; B Koo
Journal:  AJNR Am J Neuroradiol       Date:  1995-08       Impact factor: 3.825

View more
  6 in total

Review 1.  Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.

Authors:  Davide Tonduti; Luisa Chiapparini; Isabella Moroni; Anna Ardissone; Giovanna Zorzi; Federica Zibordi; Sergio Raspante; Celeste Panteghini; Barbara Garavaglia; Nardo Nardocci
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

2.  Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Authors:  Abderrahmane Hedjoudje; Gaël Nicolas; Alice Goldenberg; Catherine Vanhulle; Clémentine Dumant-Forrest; Guillaume Deverrière; Pauline Treguier; Isabelle Michelet; Lucie Guyant-Maréchal; Didier Devys; Emmanuel Gerardin; Jean-Nicolas Dacher; Pierre-Hugues Vivier
Journal:  Pediatr Radiol       Date:  2018-06-20

3.  Cardiac dysfunction in the R6/2 mouse model of Huntington's disease.

Authors:  Michael J Mihm; Deborah M Amann; Brandon L Schanbacher; Ruth A Altschuld; John Anthony Bauer; Kari R Hoyt
Journal:  Neurobiol Dis       Date:  2006-11-27       Impact factor: 5.996

Review 4.  Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review.

Authors:  Shi-Shuang Cui; Ru-Jing Ren; Ying Wang; Gang Wang; Sheng-Di Chen
Journal:  BMC Neurol       Date:  2017-08-08       Impact factor: 2.474

5.  Developmental Whole Brain White Matter Alterations in Transgenic Huntington's Disease Monkey.

Authors:  Yuguang Meng; Jie Jiang; Jocelyne Bachevalier; Xiaodong Zhang; Anthony W S Chan
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

6.  A two years longitudinal study of a transgenic Huntington disease monkey.

Authors:  Anthony Ws Chan; Yan Xu; Jie Jiang; Tayeb Rahim; Dongming Zhao; Jannet Kocerha; Tim Chi; Sean Moran; Heidi Engelhardt; Katherine Larkin; Adam Neumann; Haiying Cheng; Chunxia Li; Katie Nelson; Heather Banta; Stuart M Zola; Francois Villinger; Jinjing Yang; Claudia M Testa; Hui Mao; Xiaodong Zhang; Jocelyne Bachevalier
Journal:  BMC Neurosci       Date:  2014-03-03       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.